-
structural analyses. Perform in vitro (cell culture) and in vivo (xenograft and PDX) cancer disease modeling. Participate in novel technology development, including CRISPR gene tiling, single-cell CRISPR
-
malignancies using engineered cellular therapies. We are looking for a highly motivated candidate with a PhD and/or MD degree interested in combining novel rational and combinatorial synthetic biology approaches
-
clinical setting Your qualifications should include: · Ph.D. degree chemistry, biochemistry, structural biology, biophysics or a related discipline is required. · Knowledge of protein engineering
-
well as disease relapse in order to design novel inhibitors to intervene the malignancies; 3) collaborative analyses of myeloid cancers genomics using high-throughput single-cell technology. The group conducts
-
leukemogenesis as well as disease relapse in order to design novel inhibitors to intervene the malignancies · Collaborative analyses of myeloid cancers genomics using high-throughput single-cell technology